Objective: To examine the financial cost and demographics of genitourinary foreign object (GUFO) management at an academic institution.
Methods: This retrospective study analyzed our Genitourinary Foreign Objects database containing patients from 2012 to 2020. Healthcare costs related to GUFO management were captured from billing and collections data. Encounters were evaluated for differences between community dwelling and incarcerated patients. Patients were also evaluated for differences in repeat presentations and were stratified as single or multiple inserters.
Results: 39 patients comprising 204 encounters of inserted urethral foreign objects were reviewed in the 8-year period. Multiple encounter inserters (n=17) represented most of the encounters (n=182, 89%). Each GUFO encounter resulted in $9,479 of medical charges. Total cost during the study period was $1,876,345.32 with $899,470.87 reimbursed.
Conclusions: We present the largest single-institution series of genitourinary foreign objects to date. GUFO costs an average of $9,479 per patient encounter with a mix of community dwelling and incarcerated patients. Significant recurrent inserters were seen in both populations. This study contributes to the growing body of literature and provides a basis for the development of guidelines to improve patient care and optimize resource allocation within correctional facilities and the community. IRB: 2019-0825.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2025.03.002 | DOI Listing |
Urology
March 2025
Department of Urology, University of Wisconsin School of Medicine and Public Health, 1685 Highland Avenue, Madison, WI 53705. Electronic address:
Objective: To examine the financial cost and demographics of genitourinary foreign object (GUFO) management at an academic institution.
Methods: This retrospective study analyzed our Genitourinary Foreign Objects database containing patients from 2012 to 2020. Healthcare costs related to GUFO management were captured from billing and collections data.
Sud Med Ekspert
February 2025
Bureau of Forensic Medical Expertise of the Moscow Healthcare Department, Moscow, Russia.
Hyaluronic acid is widely used as an injectable dermal filler in medicine, especially in plastic surgery and cosmetology, due to its biocompatibility and non-immunogenicity. However, these manipulations can cause complications, the most threatening of which is non-thrombotic pulmonary embolism. The article presents a not previously described case of this complication development in a 56-year-old man who underwent penis enlargement with unknown hyaluronic acid-based drug.
View Article and Find Full Text PDFMedicina (Kaunas)
February 2025
Division of Gynaecological Oncology, Department of Gynaecology, Gynecological Obstetric Clinical Hospital, Poznan University of Medical Sciences, 33 Polna St, 60-535 Poznan, Poland.
: The most commonly encountered foreign body in the vagina is a tampon, which is routinely removed during gynaecological examinations. While these cases are common and well-known in medical practice, there are also situations involving much more unusual foreign bodies. This article focuses on these rare and often surprising cases, which can pose diagnostic and therapeutic challenges.
View Article and Find Full Text PDFToxins (Basel)
February 2025
National Veterinary School of Toulouse, ENVT, Université de Toulouse, 31076 Toulouse, France.
This study investigated biomarkers of fumonisin exposure in pigs fed diets contaminated with fumonisins at the European Union's maximum recommended level. Pigs were assigned to either a fumonisin (FB) diet or a fumonisin plus AlgoClay (FB + AC) diet for durations of 4, 9, and 14 days. At 14 days, the plasma Sa1P:So1P ratio increased in pigs fed the FB diet, while the Sa:So ratio remained unchanged.
View Article and Find Full Text PDFPLoS One
February 2025
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland.
Background: Cystoscopy-assisted submucosal injections of urethral bulking agents offer a safe and efficient alternative to surgery for treating urinary incontinence in both dogs and women. To address the concern of their transient therapeutic effect, a preclinical study evaluating the biocompatibility, safety, and durability of nanofibrillated cellulose as a bulking agent was designed. Plant-based nanofibrillated cellulose is considered renewable, biocompatible, and non-degradable in vivo.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!